Showing results (161-170 of 255) with videos related to

Sort By:
Pageof 26
European Journal of Heart Failure|July 18, 2024
Safety and efficacy of aficamten in patients with non-obstructive hypertrophic cardiomyopathy: A 36-week analysis from FOREST-HCMAhmad Masri, Roberto Barriales-Villa, Perry Elliott, et al.
Circulation. Heart Failure|November 8, 2021
Novel Small-Molecule Troponin Activator Increases Cardiac Contractile Function Without Negative Impact on EnergeticsHuamei He, Tomas Baka, James Balschi, et al.
Scientific Reports|January 2, 2023
Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathyAshley N Sharpe, Maureen S Oldach, Victor N Rivas, et al.
European Journal of Heart Failure|October 9, 2020
Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fractionAlia S Alhakak, Morten Sengeløv, Peter G Jørgensen, et al.
Transboundary and Emerging Diseases|April 1, 2018
Seroprevalence of Bluetongue Virus in small ruminants in Balochistan province, PakistanT Sohail, T Yaqub, M Shafee, et al.
European Journal of Heart Failure|March 2, 2026
Effect of the cardiac myosin activator omecamtiv mecarbil on ventricular arrhythmias, cardiac arrest, and sudden death in heart failure with reduced ejection fraction: the GALACTIC-HF trialAlberto Foà, Muthiah Vaduganathan, Brian L Claggett, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 19, 2016
Reduced force of diaphragm muscle fibers in patients with chronic thromboembolic pulmonary hypertensionEmmy Manders, Peter I Bonta, Jaap J Kloek, et al.
Lancet (London, England)|August 23, 2011
Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man studyJohn R Teerlink, Cyril P Clarke, Khalil G Saikali, et al.
Human Molecular Genetics|April 28, 2021
Acute and chronic tirasemtiv treatment improves in vivo and in vitro muscle performance in actin-based nemaline myopathy miceJosine M de Winter, Charlotte Gineste, Elisa Minardi, et al.
JACC. Heart Failure|February 1, 2024
Tricuspid Regurgitation and Clinical Outcomes in Heart Failure With Reduced Ejection FractionMarianna Adamo, Marco Metra, Brian L Claggett, et al.
Pageof 26